Effective elements of cognitive behaviour therapy for psychosis: Results of a novel type of subgroup analysis based on principal stratification

Psychological Medicine

Volumn 42, Issue 5, 2012, Pages 1057-1068

  Dunn, G ^a   Fowler, D ^b   Rollinson, R ^c   Freeman, D ^d   Kuipers, E ^d   Smith, B ^a,e   Steel, C ^f   Onwumere, J ^d   Jolley, S ^d   Garety, P ^d   Bebbington, P ^e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF READING   (United Kingdom)

Author keywords

Cognitive behavioural therapy; principal stratification; psychosis; subgroup analysis; treatment effect heterogeneity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONDON; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859223052     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711001954     Document Type: Article

References (37)

1. Angrist JD, Imbens GW, Rubin DB (1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91, 444-455. (Pubitemid 126412813)
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC.
3. Bebbington PE, Craig T, Garety P, Fowler D, Dunn G, Colbert S, Fornells-Ambrojo M, Kuipers E (2006). Remission and relapse in psychosis: operational definitions based on case-note data. Psychological Medicine 36, 1551-1562. (Pubitemid 44575801)
4. Beck AT, Steer RA, Brown GK (1996). BDI-II Manual. The Psychological Corporation: San Antonio, TX.
5. Bellamy SL, Lin JY, Have TRT (2007). An introduction to causal modelling in clinical trials. Clinical Trials 4, 58-73.
6. Chadwick P, Williams C, Mackenzie J (2003). Impact of case formulation in cognitive behaviour therapy for psychosis. Behaviour Research and Therapy 41, 67-80.
7. Cox DR, Wermuth N (1996). Multivariate Dependencies. Chapman & Hall: London.
8. Craig TJC, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, Dunn G (2004). The Lambeth Early Onset (LEO) Team: a randomised controlled trial of assertive outreach for early psychosis. British Medical Journal 329, 1067-1070. (Pubitemid 39490685)
9. Dunn G, Bentall R (2007). Modelling treatment-effect heterogeneity in randomized controlled trials of complex interventions (psychological treatments). Statistics in Medicine 26, 4719-4745. (Pubitemid 350020385)
10. Dunn G, Maracy M, Dowrick C, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V, Casey P, Wilkinson C, Vázquez-Barquero JL, Wilkinson G; The Outcomes of Depression International (ODIN) Group (2003). Estimating psychological treatment effects from an RCT with both non-compliance and loss to follow-up. British Journal of Psychiatry 183, 323-331. (Pubitemid 37243903)
11. Dunn G, Maracy M, Tomenson B (2005). Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Statistical Methods in Medical Research 14, 369-395. (Pubitemid 41300812)
12. Durham RC, Guthrie M, Morton V, Reid DA, Treliving LR, Fowler D, Macdonald RR (2003). Tayside-Fife clinical trial of cognitive behavioural therapy for medication-resistant psychotic symptoms. British Journal of Psychiatry 182, 303-311. (Pubitemid 36408281)
13. Efron B, Tibshirani RJ (1993). An Introduction to the Bootstrap. Chapman & Hall: London.
14. Emsley R, Dunn G, White IR (2010). Modelling mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Statistical Methods in Medical Research 19, 237-270.
15. Fowler D, Garety PA, Kuipers L (1995). Cognitive Behaviour Therapy for Psychosis. Wiley: Chichester.
16. Fowler D, Morley S (1989). The cognitive behavioural treatment of hallucinations and delusions: a preliminary study. Behavioural Psychotherapy 17, 267-282. (Pubitemid 19229691)
17. Frangakis CE, Rubin DB (1999). Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes. Biometrika 86, 365-379. (Pubitemid 129767156)
18. Frangakis CE, Rubin DB (2002). Principal stratification in causal inference. Biometrics 58, 21-29. (Pubitemid 34194484)
19. Garety PA, Fowler D, Freeman D, Bebbington P, Dunn G, Kuipers E (2008). A randomised controlled trial of cognitive behavioural therapy and family intervention for the prevention of relapse and reduction of symptoms in psychosis. British Journal of Psychiatry 192, 412-423. (Pubitemid 351809893)
20. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE (2001). Theoretical paper: a cognitive model of the positive symptoms of psychosis. Psychological Medicine 31, 189-195. (Pubitemid 32166387)
21. Horvitz-Lennon M, O'Malley AJ, Frank RG, Normand SLT (2005). Improving traditional intention-to-treat analysis: a new approach. Psychological Medicine 35, 961-970. (Pubitemid 41015695)
22. Jones C, Cormac I, Silveira Da Mota Neto JI, Campbell C (2004). Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews Issue 4, Art. No. CD000524.
23. Kay RS (1991). Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Brunner/Mazel, Inc.: New York.
24. Leucht S, Arbter D, Engel RR, Kissling W, Davis JM (2009). How effective are second generation anti-psychotic drugs? A meta-analysis of placebo controlled trials. Molecular Psychiatry 14, 429-447.
25. Little RJA, Rubin DB (2002). Statistical Analysis with Missing Data, 2nd edn. John Wiley & Sons: Hoboken, NJ.
26. Muthén LK, Muthén BO (1998-2009). Mplus User's Guide. Muthén & Muthén: Los Angeles, CA.
27. NICE (2009). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). National Institute of Clinical and Health Excellence: London.
28. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C (2002). Psychological treatments in schizophrenia. I: Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 32, 763-782. (Pubitemid 34823330)
29. Rollinson R, Haig C, Warner R, Garety P, Kuipers E, Freeman D, Bebbington P, Dunn G, Fowler D (2007). The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Psychiatric Services 58, 1297-1302. (Pubitemid 350043580)
30. Rollinson R, Smith B, Steel C, Jolley S, Onwumere J, Garety PA, Kuipers E, Freeman D, Bebbington PE, Dunn G, Startup M, Fowler D (2008). Measuring adherence in CBT for psychosis: a psychometric analysis of an adherence scale. Behavioural and Cognitive Psychotherapy 36, 163-178. (Pubitemid 351550696)
31. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR (2000). A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 57, 165-172. (Pubitemid 30075268)
32. Serfaty MA, Hawaorth D, Blanchard M, Buszewicz M, Murad S, King M (2009). Clinical effectiveness of individual cognitive behavioural therapy for depressed older people in primary care. Archives of General Psychiatry 66, 1332-1340.
33. Startup M, Jackson M, Pearce E (2002). Assessing therapist adherence to cognitive-behaviour therapy for psychosis. Behavioural and Cognitive Psychotherapy 30, 329-339.
34. WHO (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostic Guidelines. World Health Organization: Geneva.
35. Wykes T, Steel C, Everitt B, Tarrier N (2008). Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 34, 523-537.
36. Young JE, Beck AT (1980). Cognitive Therapy Scale: Rating Manual. Center for Cognitive Therapy: Philadelphia, PA.
37. Zimmerman G, Favrod J, Trieu VH, Pomini V (2005). The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophrenia Research 77, 1-9. (Pubitemid 40957056)